AskBorsa

Macro Group Pharmaceuticals - Macro Capital S.A.E

MCRO
Fiscal year starts in January · currency EGP · latest: Q3 2025
Net profit · 2025
116million
403.8% vs 2024
Total assets · 2025
778million
26.4% vs 2024
Shareholders' equity · 2025
194million
148.3% vs 2024
Operating cash flow · 2025

Key facts

Source: annual statements 2025
  • Macro Group Pharmaceuticals - Macro Capital S.A.E's net profit in 2025 was 116 million EGP, up 403.8% from -38.1 million EGP in 2024.
  • Total assets at the end of 2025 were 778 million EGP, and shareholders' equity 194 million EGP.
AI summary

Preparing a summary of the latest results…

Annual net profit last 5 years
Net profit
148million
174million
−273million
−38.1million
116million
20212022202320242025

Summarised financial statements

Excel · Pro
Swipe the table to see the other years.
Item · EGP20212022202320242025
Income statement
Net profit148 million174 million-273 million-38.1 million116 million
Gross profit480 million576 million313 million340 million627 million
Total assets577 million850 million514 million615 million778 million
Total liabilities219 million387 million419 million537 million584 million
Shareholders' equity358 million463 million94.33 million78.1 million194 million
Total liabilities and equity577 million850 million514 million615 million778 million
Operating cash flow50.26 million135 million-38.01 million-74.45 million
Investing cash flow-5.82 million-6.01 million-4.42 million18.56 million
Financing cash flow-44.15 million-2.5 million-69.02 million42.92 million
Net change in cash291 thousand126 million-111 million-12.97 million
Sign up free to see the full five years for every period.
Sign up free in seconds
With Google or your email, no password.

Figures in Egyptian pounds from the published statement summaries, after normalising reporting units across periods. The exact figure is in the attached report.

Financial reports (16)

Other companies in Health Care & Pharmaceuticals

Ranked by latest annual net profit
All companies in the sector